The role of oxidative stress in amyotrophic lateral sclerosis and Parkinson's disease

Neurochemical Research

Volumn 35, Issue 10, 2010, Pages 1530-1537

  Baillet, Athan ^a   Chanteperdrix, Vanessa ^a   Trocmé, Candice ^a   Casez, Pierre ^b   Garrel, Catherine ^a   Besson, Gérard ^a  

^a HÔPITAL MICHALLON   (France)

^b Department of Public Health   (France)

Author keywords

Amyotrophic lateral sclerosis; Glutathione peroxidase; Neurodegeneration; Oxidative stress; Parkinson's disease; Reactive oxygen species; Superoxide dismutase; Trace element

Indexed keywords

CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; THIOL;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NERVE CELL NECROSIS; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANTS; BIOLOGICAL MARKERS; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXIDATIVE STRESS; PARKINSON DISEASE; SEX FACTORS; SUPEROXIDE DISMUTASE; TRACE ELEMENTS;

EID: 77957562993     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-010-0212-5     Document Type: Article

References (51)

1. PH Evans E Yano J Klinowski, et al. 1992 Oxidative damage in Alzheimer's dementia, and the potential etiopathogenic role of aluminosilicates, microglia and micronutrient interactions Exs 62 178 189 1:STN:280:DyaK3s%2FotF2qtw%3D%3D 1450585
2. M Facheris S Beretta C Ferrarese 2004 Peripheral markers of oxidative stress and excitotoxicity in neurodegenerative disorders: tools for diagnosis and therapy? J Alzheimers Dis 6 177 184 1:CAS:528:DC%2BD2cXjtFOmtbc%3D 15096702
3. D Bonnefont-Rousselot L Lacomblez M Jaudon, et al. 2000 Blood oxidative stress in amyotrophic lateral sclerosis J Neurol Sci 178 57 62 1:CAS:528:DC%2BD3cXmslyjtbg%3D 10.1016/S0022-510X(00)00365-8 11018250
4. G Siciliano C D'Avino A Del Corona, et al. 2002 Impaired oxidative metabolism and lipid peroxidation in exercising muscle from ALS patients Amyotroph Lateral Scler Other Motor Neuron Disord 3 57 62 1:CAS:528: DC%2BD38XosFKjtL8%3D 10.1080/146608202760196011 12215226
5. Jenner P, Dexter DT, Sian J et al (1992) Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group. Ann Neurol 32(Suppl):S82-S87
6. P Jenner AH Schapira CD Marsden 1992 New insights into the cause of Parkinson's disease Neurology 42 2241 2250 1:CAS:528:DyaK3sXhvVyktrs%3D 1461374
7. AH Schapira VM Mann JM Cooper, et al. 1990 Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease J Neurochem 55 2142 2145 1:CAS:528:DyaK3MXpvFeltw%3D%3D 10.1111/j.1471-4159. 1990.tb05809.x 2121905
8. B Janetzky S Hauck MB Youdim, et al. 1994 Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease Neurosci Lett 169 126 128 1:CAS:528:DyaK2cXltVGrsbs%3D 10.1016/0304-3940(94)90372-7 8047266 (Pubitemid 24108879)
9. WD Parker Jr SJ Boyson JK Parks 1989 Abnormalities of the electron transport chain in idiopathic Parkinson's disease Ann Neurol 26 719 723 10.1002/ana.410260606 2557792 (Pubitemid 20011004)
10. TP Singer N Castagnoli Jr RR Ramsay, et al. 1987 Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine J Neurochem 49 1 8 1:CAS:528:DyaL2sXkslaisLs%3D 10.1111/j.1471-4159.1987.tb03384.x 3495634
11. S Przedborski V Jackson-Lewis R Djaldetti, et al. 2000 The parkinsonian toxin MPTP: action and mechanism Restor Neurol Neurosci 16 135 142 1:CAS:528:DC%2BD3cXis1aksbk%3D 12671216
12. JT Greenamyre TB Sherer R Betarbet, et al. 2001 Complex I and Parkinson's disease IUBMB Life 52 135 141 1:CAS:528:DC%2BD38Xlt1Wlsg%3D%3D 10.1080/15216540152845939 11798025
13. A Agil R Duran F Barrero, et al. 2006 Plasma lipid peroxidation in sporadic Parkinson's disease. Role of the L-dopa J Neurol Sci 240 31 36 1:CAS:528:DC%2BD2MXhtlCrt7rI 10.1016/j.jns.2005.08.016 16219327 (Pubitemid 41814950)
14. DR Rosen T Siddique D Patterson, et al. 1993 Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis Nature 362 59 62 1:CAS:528:DyaK3sXhvV2hs74%3D 10.1038/362059a0 8446170 (Pubitemid 23087289)
15. PI Oteiza OD Uchitel F Carrasquedo, et al. 1997 Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients Neurochem Res 22 535 539 1:CAS:528:DyaK2sXislymtL8%3D 10.1023/A:1027384432715 9130267
16. M Bogdanov RH Brown W Matson, et al. 2000 Increased oxidative damage to DNA in ALS patients Free Radic Biol Med 29 652 658 1:CAS:528: DC%2BD3cXnt1Sis70%3D 10.1016/S0891-5849(00)00349-X 11033417
17. MF Beal RJ Ferrante SE Browne, et al. 1997 Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis Ann Neurol 42 644 654 1:STN:280:DyaK1c%2FhvVGmtA%3D%3D 10.1002/ana.410420416 9382477 (Pubitemid 27439028)
18. N Shibata R Nagai K Uchida, et al. 2001 Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients Brain Res 917 97 104 1:CAS:528:DC%2BD3MXnsF2gsbY%3D 10.1016/S0006-8993(01)02926-2 11602233 (Pubitemid 32972133)
19. MR Cookson PJ Shaw 1999 Oxidative stress and motor neurone disease Brain Pathol 9 165 186 1:CAS:528:DyaK1MXht1Cmsbo%3D 10.1111/j.1750-3639.1999.tb00217.x 9989458
20. M Grundman 2000 Vitamin E and Alzheimer disease: the basis for additional clinical trials Am J Clin Nutr 71 630S 636S 1:STN:280:DC%2BD3c7kt1Onsg%3D%3D 10681271
21. M Sano C Ernesto RG Thomas, et al. 1997 A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study N Engl J Med 336 1216 1222 1:CAS:528: DyaK2sXivFylsrs%3D 10.1056/NEJM199704243361704 9110909 (Pubitemid 27183651)
22. A Ascherio MG Weisskopf EJ O'Reilly, et al. 2005 Vitamin E intake and risk of amyotrophic lateral sclerosis Ann Neurol 57 104 110 1:CAS:528: DC%2BD2MXpsFSkuw%3D%3D 10.1002/ana.20316 15529299 (Pubitemid 40053321)
23. C Desnuelle M Dib C Garrel, et al. 2001 A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group Amyotroph Lateral Scler Other Motor Neuron Disord 2 9 18 1:CAS:528:DC%2BD3MXktlCjt7g%3D 10.1080/146608201300079364 11465936 (Pubitemid 32472143)
24. TPS Group 1996 Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Parkinson Study Group Ann Neurol 39 37 45 10.1002/ana.410390107 (Pubitemid 26052215)
25. PS Group 1993 Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. The Parkinson Study Group N Engl J Med 328 176 183 10.1056/NEJM199301213280305 (Pubitemid 23021504)
26. K Fukunaga M Yoshida N Nakazono 1998 A simple, rapid, highly sensitive and reproducible quantification method for plasma malondialdehyde by high-performance liquid chromatography Biomed Chromatogr 12 300 303 1:CAS:528:DyaK1cXmsVynsL8%3D 10.1002/(SICI)1099-0801(199809/10)12:5<300::AID- BMC751>3.0.CO;2-# 9787903 (Pubitemid 28457191)
27. GL Ellman 1959 Tissue sulfhydryl groups Arch Biochem Biophys 82 70 77 1:CAS:528:DyaG1MXotl2ksA%3D%3D 10.1016/0003-9861(59)90090-6 13650640
28. RL Levine D Garland CN Oliver, et al. 1990 Determination of carbonyl content in oxidatively modified proteins Methods Enzymol 186 464 478 1:CAS:528:DyaK3MXksVGhtLY%3D 10.1016/0076-6879(90)86141-H 1978225 (Pubitemid 20279989)
29. S Marklund G Marklund 1974 Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase Eur J Biochem 47 469 474 1:CAS:528:DyaE2MXhtlGm 10.1111/j.1432-1033.1974. tb03714.x 4215654
30. MJ Richard F Belleville J Chalas, et al. 1997 Glutathione peroxidases: value of their determination in clinical biology Ann Biol Clin (Paris) 55 195 207 1:CAS:528:DyaK2sXlvFyqu7s%3D
31. AC Maehly B Chance 1954 The assay of catalases and peroxidases Methods Biochem Anal 1 357 424 1:STN:280:DyaG2M%2FgsFWitw%3D%3D 10.1002/9780470110171. ch14 13193536
32. LP Rowland 2000 Six important themes in amyotrophic lateral sclerosis (ALS) research, 1999 J Neurol Sci 180 2 6 1:CAS:528:DC%2BD3cXot12ru7c%3D 10.1016/S0022-510X(00)00428-7 11090857
33. K Zarkovic 2003 4-Hydroxynonenal and neurodegenerative diseases Mol Aspects Med 24 293 303 1:CAS:528:DC%2BD3sXlvVClsb0%3D 10.1016/S0098-2997(03) 00024-4 12893007 (Pubitemid 36945029)
34. E Martignoni F Blandini L Godi, et al. 1999 Peripheral markers of oxidative stress in Parkinson's disease. The role of L-DOPA Free Radic Biol Med 27 428 437 1:CAS:528:DyaK1MXltlKrsbo%3D 10.1016/S0891-5849(99)00075-1 10468218 (Pubitemid 29395437)
35. CW Olanow WG Tatton 1999 Etiology and pathogenesis of Parkinson's disease Annu Rev Neurosci 22 123 144 1:CAS:528:DyaK1MXhvFemsro%3D 10.1146/annurev. neuro.22.1.123 10202534 (Pubitemid 29144883)
36. R Saraymen E Kilic S Yazar, et al. 2003 Influence of sex and age on the activity of antioxidant enzymes of polymorphonuclear leukocytes in healthy subjects Yonsei Med J 44 9 14 1:CAS:528:DC%2BD3sXislKnsL4%3D 12619169
37. EM Kawamoto CD Munhoz I Glezer, et al. 2005 Oxidative state in platelets and erythrocytes in aging and Alzheimer's disease Neurobiol Aging 26 857 864 1:CAS:528:DC%2BD2MXhsVyqur0%3D 10.1016/j.neurobiolaging.2004.08.011 15718044 (Pubitemid 40249488)
38. F Bracco M Scarpa A Rigo, et al. 1991 Determination of superoxide dismutase activity by the polarographic method of catalytic currents in the cerebrospinal fluid of aging brain and neurologic degenerative diseases Proc Soc Exp Biol Med 196 36 41 1:CAS:528:DyaK3MXhtFOgs74%3D 1984240
39. MK Barthwal N Srivastava R Shukla, et al. 1999 Polymorphonuclear leukocyte nitrite content and antioxidant enzymes in Parkinson's disease patients Acta Neurol Scand 100 300 304 1:STN:280:DC%2BD3c%2FgsFejug%3D%3D 10.1111/j.1600-0404.1999.tb00400.x 10536916
40. K Sudha AV Rao S Rao, et al. 2003 Free radical toxicity and antioxidants in Parkinson's disease Neurol India 51 60 62 1:STN:280:DC%2BD3szjtlClsQ%3D%3D 12865518
41. B Bao AS Prasad FW Beck, et al. 2008 Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cell disease patients Transl Res 152 67 80 1:CAS:528:DC%2BD1cXpt1Kit7Y%3D 10.1016/j.trsl.2008.06.001 18674741
42. AS Prasad FW Beck B Bao, et al. 2007 Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress Am J Clin Nutr 85 837 844 1:CAS:528: DC%2BD2sXjtleqtbw%3D 17344507
43. S Taysi O Cikman A Kaya, et al. 2008 Increased oxidant stress and decreased antioxidant status in erythrocytes of rats fed with zinc-deficient diet Biol Trace Elem Res 123 161 167 1:CAS:528:DC%2BD1cXmtFehur0%3D 10.1007/s12011-008-8095-x 18273565
44. I Messaoudi J El Heni F Hammouda, et al. 2009 Protective effects of selenium, zinc, or their combination on cadmium-induced oxidative stress in rat kidney Biol Trace Elem Res 130 152 161 1:CAS:528:DC%2BD1MXnt12ru7o%3D 10.1007/s12011-009-8324-y 19214400
45. A Alexandrova A Kebis C Misl'anova, et al. 2007 Copper impairs biliary epithelial cells and induces protein oxidation and oxidative DNA damage in the isolated perfused rat liver Exp Toxicol Pathol 58 255 261 1:CAS:528: DC%2BD2sXitVCrsLc%3D 10.1016/j.etp.2006.09.001 17127046 (Pubitemid 44855541)
46. SJ Kish C Morito O Hornykiewicz 1985 Glutathione peroxidase activity in Parkinson's disease brain Neurosci Lett 58 343 346 1:CAS:528:DyaL2MXlsFymsr0%3D 10.1016/0304-3940(85)90078-3 4047494 (Pubitemid 15230680)
47. L Gil W Siems B Mazurek, et al. 2006 Age-associated analysis of oxidative stress parameters in human plasma and erythrocytes Free Radic Res 40 495 505 1:CAS:528:DC%2BD28Xis1Cjtbo%3D 10.1080/10715760600592962 16551576
48. G Mehmetcik N Alptekin G Toker, et al. 1997 Mitochondrial lipid peroxides and antioxidant enzymes in the liver following phorone-induced glutathione depletion Res Commun Mol Pathol Pharmacol 96 353 356 1:CAS:528: DyaK2sXltlGrurs%3D 9261894
49. M Rondanelli GV Melzi d'Eril A Anesi E Ferrari 1997 Altered oxidative stress in healthy old subjects Aging (Milano) 9 221 223 1:CAS:528: DyaK2sXmtVGmsr4%3D
50. S Przedborski DM Donaldson PL Murphy, et al. 1996 Blood superoxide dismutase, catalase and glutathione peroxidase activities in familial and sporadic amyotrophic lateral sclerosis Neurodegeneration 5 57 64 1:STN:280:DyaK283pvVOjsA%3D%3D 10.1006/neur.1996.0008 8731383 (Pubitemid 26132268)
51. A Storch WH Jost P Vieregge, et al. 2007 Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease Arch Neurol 64 938 944 10.1001/archneur.64.7.nct60005 17502459 (Pubitemid 47047992)